CLINICAL_TRIALS
research
· 2026-04-20
Clinical Trial Update: A Study Evaluating APG777 in Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial update for APG777 in atopic dermatitis, with the study currently active and not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apogee Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING